The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Clinical trial NCT01707849 · COMPLETED

Trial details

NCT number: NCT01707849
Sponsor: Hospital Vall d'Hebron
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C Recurrence After Liver Transplant

Start date: 2012-10-01
Primary completion: 2016-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.